glp 1 for mast cell activation syndrome GLP-1s in MCAS with Dr. Tania Dempsey - Matters: Deep dives on MCAS with Tania Dempsey, MD - Presented by The POTScast As a clinician who treats

FDA Approval Criteria: For FDA approval as weight loss medication, drugs must demonstrate: Efficacy Requirements: At least 5% average weight loss greater than placebo At least 35% of patients lose 5% body weight At least 15% of patients lose 10% body weight Safety Requirements: Acceptable safety profile in clinical trials Benefits outweigh risks Appropriate for long-term use All newer GLP-1 medications far exceed the minimum efficacy requirements, which explains their dominance

The government, responding to safety concerns, decided that Medicare would not cover any weight loss drugs, and this restriction has remained in place ever since

1995;28(Suppl):S6780

A widely observed daily dose is 250mcg , or 2-4mcg per kg

Studied for over 20 years, ME-3 has been found to support healthy glutathione levelsa key to healthy liver function.* Glutathione is the bodys Master Antioxidant. It is used by every cell in the human body, and its absolutely vital for hepatic function